Skip to main content
Published locations for Early phase 2 data: Mocetinostat/durvalumab combo shows promise in mNSCLC
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Early phase 2 data: Mocetinostat/durvalumab combo shows promise in mNSCLC
User login
Username
Password
Reset your password
/content/early-phase-2-data-mocetinostat/durvalumab-combo-shows-promise-mnsclc
/oncologypractice/article/184513/lung-cancer/early-phase-2-data-mocetinostat/durvalumab-combo-shows
/hematology-oncology/article/184513/lung-cancer/early-phase-2-data-mocetinostat/durvalumab-combo